North Norfolk health body wins patient safety award for blood clotting treatment

Christine Walton, NN CCG prescribing adviser (left) and head of primary care Sally Ross-Benham with

Christine Walton, NN CCG prescribing adviser (left) and head of primary care Sally Ross-Benham with the Patient Safety: Optimal INR Control award. Picture: NN CCG - Credit: Archant

A health body has won a patient safety award for administering a drug used to control blood clotting. North Norfolk Clinical Commissioning Group (NN CCG) was amongst the winners at the CCG Prescriber awards for its use of warfarin - one of the highest risk medications if incorrectly dosed.

GP practices within the group acheived a target range to manage blood clotting of 85pc for 1336 warfarin patients compared to an average of between 59-65pc.

The CCG also had the best INR monitoring rate, with 92pc of patients retested within 60 days.

NN CCG prescribing adviser Christine Walton said: 'We are really pleased to have been recognised for this award. Patient safety is one of our highest priorities so this is a great achievement for our GP practices.'

A total of 46 CCGs qualified for the awards with nominees in the top 10pc for performance in delivering medicine management.

Prescribing Services Ltd CCG liaison manager Keri Whitmore said: 'The opportunity to recognise CCG teams that are achieving excellence in patient safety is a core part of our conference each year. Congratulations to all the qualifying CCGs. Collectively you are leading the way in patient safety across the NHS.'

Most Read

Become a Supporter

This newspaper has been a central part of community life for many years. Our industry faces testing times, which is why we're asking for your support. Every contribution will help us continue to produce local journalism that makes a measurable difference to our community.

Become a Supporter